Other Fragile X Syndrome FAQs

Basic information for topics, such as “What is it?” is available in the About Fragile X syndrome section. Answers to other frequently asked questions (FAQs) specific to Fragile X syndrome are in this section.


  1. Eunice Kennedy Shriver National Institute of Child Health and Human Development. (2009). NIH Research Plan on Fragile X Syndrome and Associated Disorders (NA). Retrieved June 8, 2012, from https://www.nichd.nih.gov/sites/default/files/publications/pubs/Documents/nih_fragilex_research_plan_2009.pdf (PDF 440 KB)
  2. Berry-Kravis, E., Raspa, M., Loggin-Hester, L., Bishop, E., Holiday, D., & Bailey, D. B. (2010). Seizures in fragile X syndrome: Characteristics and comorbid diagnoses. American Journal of Intellectual and Developmental Disabilities, 115, 461-472.
  3. Schultz-Pedersen, S., Hasle, H., Olsen, J. H., & Friedrich, U. (2001). Evidence of decreased risk of cancer in individuals with fragile X. American Journal of Medical Genetics, 103, 226-230.
  4. Sherman, S., Pletcher, B. A., & Driscoll, D. A. (2005). Fragile X syndrome: Diagnostic and carrier testing. Genetics in Medicine, 7, 584–587.
  5. Nolin, S. L., Brown, W. T., Glicksman, A., Houck, G. E., Jr., Gargano, A. D., Sullivan, A., et al. (2003). Expansion of the Fragile X CGG repeat in females with premutation or intermediate alleles. American Journal of Human Genetics, 72, 454-464.


top of pageBACK TO TOP